GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Philogen SpA (MIL:PHIL) » Definitions » Accumulated Depreciation

Philogen SpA (MIL:PHIL) Accumulated Depreciation : €-17.81 Mil (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Philogen SpA Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Philogen SpA's quarterly accumulated depreciation increased from Dec. 2023 (€-15.73 Mil) to Jun. 2024 (€-17.28 Mil) and increased from Jun. 2024 (€-17.28 Mil) to Dec. 2024 (€-17.81 Mil).

Philogen SpA's annual accumulated depreciation increased from Dec. 2022 (€-2.92 Mil) to Dec. 2023 (€-15.73 Mil) and increased from Dec. 2023 (€-15.73 Mil) to Dec. 2024 (€-17.81 Mil).


Philogen SpA Accumulated Depreciation Historical Data

The historical data trend for Philogen SpA's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Philogen SpA Accumulated Depreciation Chart

Philogen SpA Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Accumulated Depreciation
-7.97 -9.62 -2.92 -15.73 -17.81

Philogen SpA Semi-Annual Data
Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Accumulated Depreciation Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.92 -13.83 -15.73 -17.28 -17.81

Philogen SpA Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.


Philogen SpA Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of Philogen SpA's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.


Philogen SpA Business Description

Traded in Other Exchanges
Address
Piazza La Lizza No. 7, Siena, ITA, 53100
Philogen SpA is a biotechnology company. The company develops biotech products for the imaging and therapy of life-threatening diseases. The company's focus is predominantly related to oncology drug development, although the company has also brought products for the treatment of chronic inflammatory diseases to the clinic. Its pipeline products include Nidlegy; Fibromun; Darleukin; Dodekin; Dekavil and others. Geographically, the company operates in the European Union, Switzerland, and the United States of America.

Philogen SpA Headlines

From GuruFocus